ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "practice guidelines"

  • Abstract Number: 0168 • ACR Convergence 2024

    Real-world Glucocorticoid Prescription Patterns in Patients with Lupus Nephritis: A Retrospective Study Using a Healthcare Insurance Claims Database

    Tatsuya Atsumi1, Hironari Hanaoka2, Nobuo Nishijima3, Kohji Murakami4, Mariko Nio3, Tsutomu Urakawa3, Takaaki Fujimura3 and Hiroki Hayashi5, 1Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan, Sapporo, Japan, 2Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, 3Chugai Pharmaceutical Co., Ltd., Tokyo, Japan, 4Nippon Shinyaku Co., Ltd., Tokyo, Japan, 5Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan

    Background/Purpose: Lupus nephritis (LN) is one of the most frequent organ manifestations of systemic lupus erythematosus (SLE), affecting morbidity and mortality in SLE. LN is…
  • Abstract Number: 0367 • ACR Convergence 2024

    Opinions from Rheumatoid Arthritis Patients and Providers on Discontinuing Methotrexate in Stable Disease

    Peri Newman1, Sharon Banks1, Rayford June2, Erik Lehman3, Glennys Smith4, Vandana Rai4, Nicole Wilson4, Nancy Olsen5 and Tarun Sharma4, 1Penn State Health, Hershey, PA, 2Penn State College of Medicine/Lebanon VA Medical Center, Hummelstown, PA, 3Penn State College of Medicine, Hershey, PA, 4Allegheny Health Network, Pittsburgh, PA, 5Penn State University/Milton S Hershey, Hershey, PA

    Background/Purpose: The 2021 American College of Rheumatology guidelines for treatment of rheumatoid arthritis (RA) conditionally recommend a gradual discontinuation of methotrexate (MTX) over biologic discontinuation.…
  • Abstract Number: 0674 • ACR Convergence 2024

    Hydroxychloroquine Screening Adherence: Insights from Highmark Claims Data

    Sara Shahid1, Tyson Barrett2, Sonia Manocha1 and Tanmayee Bichile1, 1Allegheny Health Network, Pittsburgh, PA, 2Highmark Health, Pittsburgh, PA

    Background/Purpose: Hydroxychloroquine (HCQ)-associated retinal toxicity and vision loss are significant challenges, with a 2% prevalence in patients using HCQ for over 10 years and up…
  • Abstract Number: 0817 • ACR Convergence 2024

    2024 Clinical Practice Guideline for the Diagnosis and Treatment of Chronic Nonbacterial Osteitis (CNO) in Adults

    Elizabeth Winter, Olaf Dekkers and Anne Leerling, and the Expert Consensus Panel for Chronic Nonbacterial Osteitis (CNO) in Adults, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: Adults with sterile bone inflammation are variably labelled as Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis (SAPHO)-syndrome, chronic nonbacterial osteomyelitis, chronic recurrent multifocal osteomyelitis (CRMO), pustulotic…
  • Abstract Number: 1070 • ACR Convergence 2024

    Evaluating & Improving Adherence to Pulmonary Hypertension Screening in Systemic Sclerosis Patients

    John Hickernell1 and Zineb Aouhab2, 1Loyola Univeristy Medical Center, Chicago, IL, 2Loyola University Medical Center, Oak Brook, IL

    Background/Purpose: Annual screening for pulmonary hypertension (PH) in patients with Systemic Sclerosis (SSc) has been shown to decrease mortality. The American College of Radiology, European…
  • Abstract Number: 1173 • ACR Convergence 2024

    Safety of Non-Exercise Rehabilitation Interventions for Adults with Rheumatoid Arthritis

    Megna Mishra1, Joshua Torrey2, Bria Dunn2 and Louise Thoma3, 1UNC Health, Cary, 2University of North Carolina-Chapel Hill, Chapel Hill, 3University of North Carolina, Chapel Hill, NC

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, systemic, inflammatory condition. Improved outcomes occur with early diagnosis, evaluation, and management. Management includes pharmacological, exercise, rehabilitation, diet,…
  • Abstract Number: 1440 • ACR Convergence 2024

    Significant Indicators Identified for Carotid Doppler Ultrasound Use in Axial Spondyloarthritis Patients Without Conventional Cardiovascular Risk Factors

    Brona Dinneen1 and Finbar O'Shea2, 1St James's Hospital,, Dublin, Dublin, Ireland, 2St James's Hospital, Dublin, Dublin, Ireland

    Background/Purpose: The EULAR  cardiovascular screening recommendations advocate for the use of carotid dopplers in patients with inflammatory joint diseases to detect subclinical atherosclerosis. Despite these…
  • Abstract Number: 1930 • ACR Convergence 2024

    Clinical Significance of Positive ENA Testing in ANA-Negative Patients: A Retrospective Analysis of Rheumatologic Diagnoses

    Bassel Bou Dargham1, Jason Huang2 and Michael Luggen3, 1University of Cincinnati Medical Center, Cincinnati, OH, 2University of Cincinnati, Cincinnati, 3University Hospital/University of Cincinnati College of Medicine, Cincinnati, OH

    Background/Purpose: On the basis of consensus methodology and literature review, the ACR has recommended that antibodies to extractable nuclear antigens (ENA), also known as subserologies…
  • Abstract Number: 2030 • ACR Convergence 2024

    The Development of the EULAR Score for the Definition of Disease Activity in Adult-onset Still’s Disease; The “DAVID” Project

    Piero Ruscitti1, Tanja Stamm2, valentin Ritschl2, Stéphane Mitrovic3, Charlotte Girard-Guyonvarc'h4, Helene Alexanderson5, Birgit Barten6, Carina Bostrøm7, Dorothea Fell8, Marco Gattorno9, Francis Guillemin10, Melanie Körner6, Martin Krusche11, Javier Llorca12, Pierre Quartier13, Angelo Ravelli9, Nicolas Rosine14, Maud Wieczorek15, Tanita Wilhelmer6, Miguel Angel Gonzalez-Gay16, Cem Gabay4, Bruno Fautrel17, Eugen Feist18 and Roberto Giacomelli19, and on behalf of GIRRCS–AOSD Study group, 1Division of Rheumatology, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy, L'Aquila, Italy, 2Institute of Outcomes Research, Center for Medical Data Science, Medical University of Vienna, Vienna, Austria, Vienna, Austria, 3Sorbonne Université – AP-HP, Hôpital Pitié Salpêtrière, Service de Rhumatologie, Paris, France – INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique, UMR S1136, Paris France – CRI-IMIDATE Network, Paris, France, 4Division of Rheumatology, Department of Medicine, University Hospital of Geneva and Faculty of Medicine University of Geneva, Geneva, Switzerland, Geneva, Switzerland, 5Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 6EULAR Research Partner, EULAR PARE, Zurich, Switzerland, Zurich, Switzerland, 7Department of Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 8Deutsche Rheuma-Liga Bundesverband e. V., Bonn, Germany, Bonn, Germany, 9IRCCS Giannina Gaslini, Genoa, Italy, 10Inserm, CHRU Nancy, Université de Lorraine, CIC-Clinical Epidemiology, Nancy, F-54000, France, Nancy, France, 11III Department of Medicine, Division of Rheumatology and Systemic Inflammatory Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, Germany, 12Epidemiology, CIBER Epidemiología y Salud Pública (CIBERESP) and Department of Medical and Surgical Sciences, University of Cantabria, Santander, Spain, Santander, Spain, 13Université de Paris, Institut des Maladies Génétiques (IMAGINE Institute), Reference Centre for Rheumatic, AutoImmune, and Systemic Diseases in Children (RAISE), Department of Pediatric Immunology, Hematology and Rheumatology, Necker Hospital, Assistance Publique-Hôpitaux de Paris, Paris 75015, France, Paris, France, 14Institut Pasteur, Université de Paris, Immunoregulation Unit, Department of Immunology, Paris, France, Paris, France, 15Swiss Centre of Expertise in Life Course Research LIVES, Lausanne and Geneva, Geneva, Switzerland, Geneva, Switzerland, 16University of Cantabria, Fundación Jimenez Díaz, Madrid, Madrid, Spain, 17INSERM, UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, and Sorbonne University – Assistance Publique-Hôpitaux de Paris, Département de Rhumatologie, Hôpital Pitié-Salpêtrière, Paris, Ile-de-France, France, 18Department of Rheumatology, Helios Clinic Vogelsang-Gommern, cooperation partner of the Otto von Guericke University Magdeburg, Gommern, Germany, 19Rheumatology, Immunology and Clinical Medicine Unit, Department of Medicine, University of Rome "Campus Bio-Medico", Roma, Italy

    Background/Purpose: Adult-onset Still's disease (AOSD) is a rare systemic inflammatory disorder of unknown aetiology usually affecting young adults. Despite the evidence increasingly reporting the efficacy…
  • Abstract Number: 2214 • ACR Convergence 2024

    Confirming a Value for Rheumatoid Arthritis Flares Based on Changes in CDAI, SDAI and RAPID3

    Irtza Badar1 and Martin Bergman2, 1Mercy Catholic Medical Center, Philadelphia, PA, 2self, Beach Haven, NJ

    Background/Purpose: To determine and revalidate the definitions of disease flares in patients with rheumatoid arthritis (RA) flares based on the changes in Clinical and Simplified…
  • Abstract Number: 2415 • ACR Convergence 2024

    Characterizing the Population with Suspected Lupus Nephritis in Care of a Community Rheumatology Network

    Nehad Soloman1, Jawad Bilal2, Romy Cabacungan3, Scott Milligan4, Andrew Sharobeem5, John Tesser6 and Henry Leher7, 1Arizona Arthritis & Rheumatology Associates, P.C., Glendale, AZ, 2University of Arizona, Tucson, AZ, 3Arizona Arthritis & Rheumatology Associates, P.C., Tucson, AZ, 4Trio Health, Louisville, CO, 5AARA, Peoria, AZ, 6Arizona Arthritis & Rheumatology Associates, Phoenix, AZ, 7Aurinia Pharma, Stowe, VT

    Background/Purpose: Lupus nephritis (LN) has been estimated to develop in up to 40% of all patients with systemic lupus erythematosus (SLE), with higher rates in…
  • Abstract Number: 1856 • ACR Convergence 2023

    Improving Recombinant Zoster Vaccination Rates in Patients Receiving Immunosuppressive Therapy in the Rheumatology Clinic at the Orlando VA Healthcare System – a Quality Improvement Project

    Kathlyn Camargo Macias1, Ravi Shahu Khal1, Ariail Schmitz2, Kathleen McCabe1, Taylor Kann1, Marilyn Mosquera3 and Ashwini Komarla4, 1University of Central Florida, Orlando, FL, 2University of Central Florida, St. Cloud, FL, 3University of Central Florida, Casselberry, FL, 4ORLANDO VAMC, Orlando, FL

    Background/Purpose: Herpes zoster is a painful rash that involves one to three adjacent dermatomes, secondary to reactivation of latent varicella-zoster virus (VZV). About 95 %…
  • Abstract Number: 1954 • ACR Convergence 2023

    Evaluation of Cancer Screening Methods in Patients Diagnosed with Inflammatory Muscle Disease at Kansas University Medical Center

    Padmini Giri1, Amrita Bath2 and Pooja Bhadbhade2, 1University of Kansas Medical Center, Overland Park, KS, 2University of Kansas Medical Center, Kansas City, MO

    Background/Purpose: Idiopathic inflammatory myopathies (IIM) are characterized by muscle weakness and inflammation. There is an increased risk of developing cancer in patients (pts) with IIM…
  • Abstract Number: 2009 • ACR Convergence 2023

    Screening and Treatment of Low Bone Mineral Density in Allogeneic Hematopoietic Cell Transplant Patients

    Perry Fuchs, Christina Ferraro, Chao Zhang, Chad Deal, Betty Hamilton and Sarah Keller, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: Bone mineral density (BMD) loss and fracture are important causes of increased morbidity following allogeneic hematopoietic stem cell transplant (allo-HCT).Recent societal recommendations support screeningDual…
  • Abstract Number: 2459 • ACR Convergence 2023

    Reporting of Race and Ethnicity in Lupus Publications in High-impact Rheumatology Journals

    Idil Eroglu, Hailey Baker, Mario Felix and Lisa Suter, Yale School of Medicine, New Haven, CT

    Background/Purpose: Reporting of race and ethnicity as social constructs is critical to highlight equity and diversity of study participants, with the knowledge that socio-economic factors…
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology